Problem Solution: Gene One
Gene One is known for its groundbreaking gene technology that was introduced to the world in 1996. Since then it has gown to a $400 million company in just eight years (Scenario, 2007).
Don Ruiz, the DEO of Gene One is looking to move this company into the future with high profits, new and innovative technology and a place on Wall Street with an IPO offering. Don and his leadership team have the approval of the Board to move forward with their 36-month plan to capture growth of 40%, create new technology and introduce six new products, raise capital and set up the IPO. While this was approved by the Board this plan has already been faced with dilemmas and doubts form Board members, the leadership team and employees.
In this paper we will examine the problems of this plan, the risk and probability and consequences of this plan. We will discuss some alternatives to assist Gene One in their quest for the technology and the IPO. We will look at the end results that Gene One ultimately seek to achieve with this plan and within the analysis we can see key concepts that support the analysis.
Situation Analysis
Issue and Opportunity Identification
Biotechnology is growing increasingly among investors on Wall Street and Gene One’s CEO, Don Ruiz has found that it would be in the best interest of the company to go public with the business within the next 36 months. Don and his Board members have devised a clear plan to implement this process with the aid of the leadership team. The problems with this plan for the next 36 months will include all of the initial key points to have 40% growth target, raise capital and develop two new technologies and introduce six new products with current techn ...